Skip to main content
. 2020 Oct 29;25(21):5020. doi: 10.3390/molecules25215020
BAL bronchoalveolar lavage
BALF bronchoalveolar lavage fluid
BAP 6-benzylaminopurine
b.w. body weight
cDNA complementary DNA
COPD chronic obstructive pulmonary disease
COX-2 cyclooxygenase-2
CRP C-reactive protein
DC dendritic cell
E1 extracts from roots of field cultivated Platycodon grandiflorum
E2 extracts from biotransformed roots of Platycodon grandiflorum
E3 extracts from callus of Platycodon grandiflorum
ELISA enzyme-linked immunosorbent assay
GAPDH glyceraldehyde 3-phosphate dehydrogenase
PG Platycodon grandiflorum
HPLC high-performance liquid chromatography
HPLC-DAD-MSn diode-array detection and electrospray ionization tandem mass spectrometry
IgE immunoglobulin E
IL-13 interleukin-13
IL-6 interleukin 6
iNOS inducible nitric oxide synthase
LC-MS liquid chromatography–mass spectrometry
MAPK mitogen activated protein kinase
MBS sodium metabisulfite
MCP-1 monocytic chemotactic protein-1
NAA naphthaleneacetic acid
mRNA messenger RNA
MUC5AC mucin 5AC
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells
PCR polymerase chain reaction
qPCR quantitative polymerase chain reaction
qRT-PCR quantitative reverse transcription polymerase chain reaction
RAW 264.7 cells monocyte/macrophage-like cell line RAW 264.7
RNA ribonucleic acid
SO2 sulfur dioxide
TGF-β1 transforming growth factor beta 1
TGF-β2 transforming growth factor-beta 2
TGF-β3 transforming growth factor beta 3
Th T helper
Th1 Th type-1
Th2 Th type-2
TNF-alfa tumor necrosis factor alfa
UPLC ultra-performance liquid chromatography
UPLC-MS/MS ultra-performance liquid chromatography-tandem mass spectrometry
VEGF vascular endothelial growth factor
HHS Vulnerability Disclosure